More on WPI
Data
Financials
News
|
Watson Pharmaceuticals, Inc. (NY:WPI)
Delayed: 85.73
--0 (-0%)
|
Trade Now! |
|
| Previous Close |
$85.73 |
|
52 Week High |
$91.47 |
|
| Open |
$16.30 |
|
52 Week Low |
$57.16 |
| Day High |
$85.73 |
|
P/E |
66.46 |
| Day Low |
$85.73 |
|
EPS |
$1.29 |
| Volume |
3,625 |
|
|
|
-
May 15, 2013 03:56 PM
Cooperman's Omega Advisors Gets Into Gold and Silver ETFs (GLD) (GDX) (SLV) (more...)
-
Apr 25, 2013 10:18 AM
Shire plc (SHPG) Settles INTUNIV Litigation with Actavis (ACT), Watson (WPI)
-
Mar 5, 2013 11:50 AM
Pfizer (PFE) Ticks Higher on Extension of Celebrex Exclusivity; Unleases Lawsuits (TEVA) (MYL)
-
Feb 13, 2013 12:04 PM
Cooperman's Omega Advisors Shows New Stakes in Facebook (FB), Crocs (CROX) and Freeport-McMoRan (FCX)
-
Jan 23, 2013 10:04 AM
Notable Mergers and Acquisitions of the Day 01/23: (AGN)/(MAPP) (CSCO) (WPI)
-
Jan 23, 2013 07:32 AM
Watson Pharma (WPI) Acquires Uteron Pharma SA in $305M Deal
-
Jan 11, 2013 07:28 AM
Goldman Sachs Downgrades Watson Pharmaceuticals (WPI) to Neutral
-
Jan 8, 2013 04:35 PM
Watson Pharma (WPI) to Reorganize Corona, CA, Facility; Sees Charges
-
Jan 3, 2013 09:02 AM
Watson Pharma (WPI) Unit Receives Approval for Generic Lysteda ANDA
-
Dec 31, 2012 02:43 PM
Stocks Crossing 50-Day SMA 12/31: (HPQ) (ZNGA) (MCP) Above; (PFE) (VVUS) (WPI) Below
View All Articles
-
Nov 1, 2012 06:45 AM
Watson Pharmaceuticals, Inc. (WPI) Tops Q3 EPS by 6c; Guides FY12 EPS Above Views
-
Jul 26, 2012 07:58 AM
Watson Pharma (WPI) Raises FY12 EPS Outlook, Affirms Sales Guidance
-
Jul 26, 2012 07:06 AM
Watson Pharmaceuticals, Inc. (WPI) Reports Solid Q2 Results
-
Apr 30, 2012 07:01 AM
Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales
-
Apr 25, 2012 04:55 PM
Watson (WPI) to Acquire Actavis in EUR 4.25B Deal; Could Be More on Performance Considerations
-
Feb 14, 2012 07:01 AM
Watson Pharmaceuticals, Inc. (WPI) Tops Q4 EPS by 1c; Guides FY12 EPS
-
Jan 24, 2012 06:33 AM
Watson Pharma (WPI) Preliminary FY11 Numbers Top Views; Guides FY12 EPS, Revs
-
Nov 1, 2011 07:02 AM
Watson Pharmaceuticals (WPI) Tops Q3 EPS by 4c; Updates FY11 Outlook
-
Jul 26, 2011 07:06 AM
Watson Pharmaceuticals (WPI) Tops Q2 EPS by 1c; Guides FY11 Sales
View All Major News
-
May 15, 2013 03:56 PM
Cooperman's Omega Advisors Gets Into Gold and Silver ETFs (GLD) (GDX) (SLV) (more...)
-
Apr 25, 2013 10:18 AM
Shire plc (SHPG) Settles INTUNIV Litigation with Actavis (ACT), Watson (WPI)
-
Mar 5, 2013 11:50 AM
Pfizer (PFE) Ticks Higher on Extension of Celebrex Exclusivity; Unleases Lawsuits (TEVA) (MYL)
-
Feb 13, 2013 12:04 PM
Cooperman's Omega Advisors Shows New Stakes in Facebook (FB), Crocs (CROX) and Freeport-McMoRan (FCX)
-
Jan 23, 2013 10:04 AM
Notable Mergers and Acquisitions of the Day 01/23: (AGN)/(MAPP) (CSCO) (WPI)
-
Jan 23, 2013 07:32 AM
Watson Pharma (WPI) Acquires Uteron Pharma SA in $305M Deal
-
Jan 11, 2013 07:28 AM
Goldman Sachs Downgrades Watson Pharmaceuticals (WPI) to Neutral
-
Jan 8, 2013 04:35 PM
Watson Pharma (WPI) to Reorganize Corona, CA, Facility; Sees Charges
-
Jan 3, 2013 09:02 AM
Watson Pharma (WPI) Unit Receives Approval for Generic Lysteda ANDA
-
Dec 31, 2012 02:43 PM
Stocks Crossing 50-Day SMA 12/31: (HPQ) (ZNGA) (MCP) Above; (PFE) (VVUS) (WPI) Below
View All Reports